According to the National Institutes of Health (NIH), a disease is considered rare if it affects fewer than 200,000 individuals in the United States. The NIH currently identifies roughly 7,000 diseases as rare or “orphan” diseases.
Approximately 47% (21 of 45) of all novel drugs approved by the Food and Drug Administration (FDA) in 2015 were indicated to treat rare diseases. US Bioservices dispenses treatments for a number of rare diseases, including:
- DMD – Duchenne’s Muscular Dystrophy
- Dupuytren’s Contracture
- Congenital Sucrase-Isomaltase Deficiency (CSID) / Genetic Sucrase-Isomaltase Deficiency (GSID)
- Idiopathic Thrombocytopenic Purpura
- Peyronie’s Disease
- Sickle Cell Anemia